日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits

体外细胞介导的人类免疫缺陷病毒感染者和未感染者对巨细胞病毒全抗原及其亚单位的免疫反应

Weinberg, A; Spritzler, J; Nokta, M; Schrier, R; Landay, A; Brown, D; Pollard, R

Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group

对 TruCount 绝对计数管在测定人类免疫缺陷病毒阳性成人 CD4 和 CD8 细胞数量方面的应用进行评估。研究中心研究人员和美国国家过敏症和传染病研究所 (NIAID) 传染病和艾滋病新技术评估小组

Schnizlein-Bick, C T; Spritzler, J; Wilkening, C L; Nicholson, J K; O'Gorman, M R

Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group

采用单平台与多平台方法对CD4和CD8 T淋巴细胞进行计数的多中心比较:贝克曼库尔特流式计数荧光微球和tetraONE系统的评估。美国国家过敏症和传染病研究所(NIAID)艾滋病新技术评估组

Reimann, K A; O'Gorman, M R; Spritzler, J; Wilkening, C L; Sabath, D E; Helm, K; Campbell, D E

Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.

需要建立细胞因子、趋化因子和免疫激活血浆标志物的外部能力验证计划

Fahey J L, Aziz N, Spritzler J, Plaeger S, Nishanian P, Lathey J L, Seigel J, Landay A L, Kilarui R, Schmitz J L, White C, Wara D W, Akridge R, Cutili J, Douglas S D, Reuben J, Shearer W T, Nokta M, Polland R, Schooley R, Asthana D, Mizrachi Y, Waxdal M